NAGASAWA Hayato | Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
スポンサーリンク
概要
- NAGASAWA Hayatoの詳細を見る
- 同名の論文著者
- Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical Universityの論文著者
Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University | 論文
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
- Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis